Lumos Pharma IncNASDAQ:LUMO
- LAST PRICE4.3000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots4.2500/ 1
- Ask / Lots4.3000/ 4
- Open / Previous Close--- / 4.3000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | LUMO |
|---|---|---|
| 09:32 ET | 17962 | 4.2995 |
| 09:33 ET | 6543 | 4.32 |
| 09:35 ET | 44895 | 4.28 |
| 09:37 ET | 50321 | 4.28 |
| 09:39 ET | 890 | 4.28 |
| 09:42 ET | 600 | 4.28 |
| 09:44 ET | 4200 | 4.3 |
| 09:46 ET | 100 | 4.3 |
| 09:48 ET | 200 | 4.3 |
| 10:02 ET | 200 | 4.3 |
| 10:04 ET | 9902 | 4.31 |
| 10:06 ET | 300 | 4.32 |
| 10:09 ET | 100 | 4.31 |
| 10:18 ET | 100 | 4.31 |
| 10:20 ET | 100 | 4.31 |
| 10:22 ET | 1400 | 4.31 |
| 10:24 ET | 100 | 4.31 |
| 10:27 ET | 3108 | 4.31 |
| 10:29 ET | 8665 | 4.305 |
| 10:33 ET | 200 | 4.32 |
| 10:36 ET | 520 | 4.32 |
| 10:38 ET | 100 | 4.32 |
| 10:40 ET | 900 | 4.3 |
| 10:42 ET | 100 | 4.3 |
| 10:44 ET | 300 | 4.31 |
| 10:58 ET | 100 | 4.32 |
| 11:02 ET | 100 | 4.32 |
| 11:03 ET | 2412 | 4.3132 |
| 11:07 ET | 200 | 4.32 |
| 11:16 ET | 6000 | 4.3 |
| 11:18 ET | 1420 | 4.3 |
| 11:20 ET | 591 | 4.3 |
| 11:30 ET | 3846 | 4.3 |
| 11:32 ET | 5679 | 4.32 |
| 11:34 ET | 4079 | 4.32 |
| 11:38 ET | 100 | 4.325 |
| 11:39 ET | 3093 | 4.32 |
| 11:41 ET | 900 | 4.325 |
| 11:45 ET | 400 | 4.32 |
| 11:48 ET | 200 | 4.33 |
| 11:56 ET | 100 | 4.33 |
| 11:59 ET | 200 | 4.32 |
| 12:01 ET | 967 | 4.33 |
| 12:17 ET | 6109 | 4.31 |
| 12:19 ET | 1100 | 4.3 |
| 12:24 ET | 2184 | 4.3 |
| 12:26 ET | 100 | 4.32 |
| 12:30 ET | 100 | 4.32 |
| 12:33 ET | 100 | 4.32 |
| 12:44 ET | 100 | 4.32 |
| 12:46 ET | 100 | 4.32 |
| 12:51 ET | 100 | 4.32 |
| 12:53 ET | 1108 | 4.3 |
| 12:55 ET | 700 | 4.3 |
| 12:57 ET | 200 | 4.31 |
| 01:00 ET | 200 | 4.32 |
| 01:02 ET | 327 | 4.32 |
| 01:04 ET | 100 | 4.31 |
| 01:06 ET | 100 | 4.32 |
| 01:09 ET | 200 | 4.32 |
| 01:15 ET | 10786 | 4.29 |
| 01:18 ET | 700 | 4.3 |
| 01:20 ET | 1400 | 4.3 |
| 01:22 ET | 594 | 4.3 |
| 01:24 ET | 2280 | 4.3 |
| 01:26 ET | 500 | 4.3 |
| 01:27 ET | 200 | 4.3 |
| 01:29 ET | 100 | 4.3 |
| 01:44 ET | 200 | 4.3 |
| 01:47 ET | 100 | 4.3 |
| 01:51 ET | 2060 | 4.3 |
| 01:56 ET | 400 | 4.3 |
| 01:58 ET | 100 | 4.3 |
| 02:16 ET | 100 | 4.3 |
| 02:18 ET | 100 | 4.3 |
| 02:20 ET | 100 | 4.3 |
| 02:21 ET | 100 | 4.3 |
| 02:25 ET | 100 | 4.3 |
| 02:30 ET | 100 | 4.3 |
| 02:32 ET | 400 | 4.3 |
| 02:38 ET | 100 | 4.3 |
| 02:43 ET | 300 | 4.3 |
| 02:45 ET | 100 | 4.3 |
| 02:50 ET | 300 | 4.3 |
| 02:52 ET | 300 | 4.3 |
| 02:54 ET | 200 | 4.3 |
| 02:56 ET | 200 | 4.3 |
| 03:10 ET | 415 | 4.3 |
| 03:12 ET | 100 | 4.3 |
| 03:17 ET | 100 | 4.3 |
| 03:19 ET | 1200 | 4.3 |
| 03:21 ET | 300 | 4.3 |
| 03:24 ET | 120 | 4.3 |
| 03:26 ET | 200 | 4.3 |
| 03:30 ET | 13713 | 4.29 |
| 03:33 ET | 10200 | 4.3 |
| 03:35 ET | 900 | 4.3 |
| 03:37 ET | 918 | 4.3 |
| 03:39 ET | 900 | 4.305 |
| 03:46 ET | 100 | 4.31 |
| 03:50 ET | 100 | 4.31 |
| 03:55 ET | 100 | 4.31 |
| 03:57 ET | 1111 | 4.305 |
| 04:00 ET | 1400 | 4.3 |
Nov 21, 2024
Nov 16, 2024
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LUMO, PIK, OB on Behalf of Shareholders, from 11:14AM ET on Saturday Nov 16, 2024 by Dow Jones
11:14AM ET on Saturday Nov 16, 2024 by Dow Jones
Nov 15, 2024
$HAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Mergers of OB, LUMO, PIK and PORT, from 6:02PM ET on Friday Nov 15, 2024 by Dow Jones
6:02PM ET on Friday Nov 15, 2024 by Dow Jones
Nov 12, 2024
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LUMO, ALTR, STAF on Behalf of Shareholders, from 3:27PM ET on Tuesday Nov 12, 2024 by Dow Jones
3:27PM ET on Tuesday Nov 12, 2024 by Dow Jones$HAREHOLDER INVESTIGATION: The M&A Class Action Firm Reviews the Merger of STAF, ATSG, GABC and LUMO, from 12:02AM ET on Tuesday Nov 12, 2024 by Dow Jones
12:02AM ET on Tuesday Nov 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Lumos Pharma Inc | 37.3M | -1.0x | --- |
Barinthus Biotherapeutics PLC | 36.0M | -0.7x | --- |
HCW Biologics Inc | 32.3M | -0.6x | --- |
SAB Biotherapeutics Inc | 28.9M | -0.5x | --- |
OncoCyte Corp | 45.6M | -0.6x | --- |
Calidi Biotherapeutics Inc | 37.5M | -0.4x | --- |
Company Information
Lumos Pharma, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in advancing its clinical program and focused on identifying, acquiring, developing, and commercializing products and new therapies for people with rare diseases. Its pipeline is focused on the development of an orally administered small molecule, LUM-201, which is a growth hormone (GH) secretagogue, also called ibutamoren, for rare endocrine disorders that require injectable recombinant human growth hormone (rhGH). LUM-201 is a tablet formulation that is intended to be administered once daily. LUM-201 stimulates GH via the GH secretagogue receptor (GHSR1a), also known as the ghrelin receptor, and also suppresses the release of somatostatin, thus providing a differentiated mechanism of action to treat some rare endocrine disorders (involving a deficiency of GH) by increasing the amplitude of endogenous, pulsatile GH secretion. Lumos Pharma Sub, Inc. (Private Lumos) is its subsidiary.
Contact Information
- Headquarters
- 4200 MARATHON BLVD., SUITE 200AUSTIN, TX, United States 78756
- Phone
- 512-215-2630
- Fax
- 515-296-3520
Executives
- Chairman of the Board, Chief Executive Officer
- Richard Hawkins
- President, Chief Scientific Officer
- John Mckew
- Chief Financial Officer, Principal Accounting Officer
- Lori Lawley
- General Counsel
- Bradley Powers
- Lead Independent Director
- Thomas Raffin
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $37.3M |
|---|---|
Revenue (TTM) | $2.2M |
Shares Outstanding | 8.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.75 |
EPS | $-4.29 |
Book Value | $3.37 |
P/E Ratio | -1.0x |
Price/Sales (TTM) | 16.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,647.57% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
